NEOVACS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.185 EUR | +8.82% |
|
-8.51% | -90.75% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 1.11K 1.21K | Sales 2023 | 538K 584K | Capitalization | 278 301.77 |
|---|---|---|---|---|---|
| Net income 2022 | -3M -3.26M | Net income 2023 | -8M -8.68M | EV / Sales 2022 | - |
| Net cash position 2022 | 5.55M 6.03M | Net cash position 2023 | 237K 257K | EV / Sales 2023 | -0.44 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | 23 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0.12% |
More Fundamentals
* Assessed data
More news
| 1 day | +8.82% | ||
| 1 week | -8.51% | ||
| Current month | -43.94% | ||
| 1 month | -50.00% | ||
| 3 months | -87.99% | ||
| 6 months | -93.83% | ||
| Current year | -90.75% |
1 week
0.16
0.22
1 month
0.160.37
Current year
0.163.20
1 year
0.1624 000.00
3 years
0.161 000 000.00
5 years
0.161 000 000.00
10 years
0.161 000 000.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-21 | 0.185 | +8.82% | 28,550 |
| 24-05-20 | 0.17 | -5.40% | 46,601 |
| 24-05-17 | 0.1797 | -9.24% | 72,444 |
| 24-05-16 | 0.198 | +4.98% | 52,157 |
| 24-05-15 | 0.1886 | -0.74% | 16,530 |
Real-time Euronext Paris, May 21, 2024 at 11:35 am EDT
More quotes
NEOVACS is a major player in the therapeutic vaccines for the treatment of autoimmune and / or inflammatory diseases. Its proprietary products are vaccine candidates developed from its own technology platform for Kinoid products used in lupus disease and allergies. This innovative approach allows the patient's immune system to regulate the damage caused by overproduction of cytokines (active immunotherapy) such as IL4/IL-13/IgE. The company also uses the skills of its experienced team to invest in companies developing innovative products (BioTech) and medical devices (MedTech).
| 1st Jan change | Capi. | |
|---|---|---|
| -90.75% | 64.94K | |
| +44.48% | 54.04B | |
| +43.57% | 41.96B | |
| -0.86% | 41.92B | |
| -7.59% | 28.35B | |
| +12.30% | 26.35B | |
| -21.83% | 19B | |
| +7.15% | 13B | |
| +29.40% | 12.28B | |
| +25.15% | 12.19B |
- Stock Market
- Equities
- ALNEV Stock